For Facebook users, “targeted ads” are a way of life. I ignore them until I saw one from lawyers who were suing baby food manufacturers for causing autism. I guess that they weren’t getting anywhere with the trope that vaccines cause autism (they absolutely don’t), although the quack Del Bigtree continues to push the myth.
As I did for vaccines, I’m going to show you that baby food may or may not be linked to autism. There seem to be some problematic issues with baby food manufacturing, but that does not show a direct link to autism.
Oh yeah, one basic principle you need to understand — lawyers and judges do NOT establish science.
A pediatric phase 2 clinical trial using bacillus Calmette-Guerin vaccine, or BCG vaccine, to reverse even advanced type 1 diabetes mellitus has begun. Type 1 diabetes is considered irreversible, so if phase 2 and 3 clinical trials show that the vaccine is safe and effective in reversing diabetes, it would be one of the most important advances in medicine.
Let’s take a look at what is type 1 diabetes (since a lot of people confuse it with type 2 diabetes), the clinical trial, and other information. Maybe one of you is close enough to the trial centers so that you may, if you have type 1 diabetes, can sign up to participate in the trial.
I am very hopeful about this clinical trial, but I also know that it will take many years before we know if it works.
I have writtenotherarticles about the link between COVID-19 and diabetes, and now a new study has been published that shows an increase in new diagnoses of type 1 diabetes among children at one institution. Although it only included data from one healthcare institution, it represents more troubling data that COVID-19 may be closely linked to new cases of type 1 diabetes.
Let’s take a look at this new paper and determine what it tells us.
On 30 December 2021, the Centers for Disease Protection and Control (CDC) released two studies on COVID-19 vaccine safety for 5-11-year-olds that showed that there were few serious safety issues and showed that the vaccines prevented serious illness and hospitalization.
These two studies provide strong evidence for COVID-19 vaccine safety and effectiveness for children and should provide confidence for parents to make sure their children get the vaccine.
This post will examine these peer-reviewed articles and pull out the key data for the reader.
On 17 December 2021, Pfizer stated that trials for its pediatric COVID-19 vaccine for children ages 2 to 5 show that it did not provide the expected immunity. Therefore, it is adding a third dose to the clinical trial, and it will probably mean a significant delay in getting Emergency Use Authorization (EUA) for the COVID-19 vaccine for that age group.
Pfizer, after its independentData and Safety Monitoring Board examined the data, decided to add the third dose for all children and babes, ages 6 months to 5 years, that were included in the clinical trial. Apparently, the data showed that the two pediatric-sized doses of the Pfizer COVID-19 vaccine were not producing the expected immunity in the 2- to 5-year-old group. Although they did not have the data for babies up to two years old, they decided to add the booster to them.
The Pfizer pediatric vaccine includes a 3 microgram (µg) dose as opposed to the 10 µg dose for individuals 5-12 years old, and a 30 µg dose for those older than 12-years-old. Pfizer said that the third 3 µg dose will be given at least two months after the second dose in the two-dose series that was included in the original clinical trial protocol.
The independent Data and Safety Monitoring Board, which can see clinical trial data without giving details to the company or investigators, also indicated that there were “no safety concerns were identified and the 3 microgram dose demonstrated a favorable safety profile in children 6 months to under 5 years of age.” This should assure anyone that a third dose will not bring up any safety issues.
The decision to evaluate a third dose of 3 micrograms for children 6 months to under 5 years of age reflects the companies’ commitment to carefully select the right dose to maximize the risk-benefit profile. If the three-dose study is successful, Pfizer and BioNTech expect to submit data to regulators to support an Emergency Use Authorization (EUA) for children 6 months to under 5 years of age in the first half of 2022.
Pfizer is also planning to test third doses in older children, who do not yet have authorization for booster doses of vaccine. Kids ages 5 to 11 and 12 to 15 will get full-dose third shots in the trials.
It’s clear that Pfizer is taking extreme care with its lower-dose pediatric COVID-19 vaccine. They want to make certain that they are providing effective doses without any serious safety signals.
One final point — whenever someone makes a claim that companies somehow cheat during vaccine clinical trials, nothing could be further from the truth. Companies, such as Pfizer, institute a number of protocols and independent advisors to make certain that these clinical trials provide unbiased and quality data that support the safety and effectiveness of these vaccines.
Like all medical procedures, devices, and pharmaceuticals, vaccines are not perfect – there are rare vaccine adverse events. What matters is that the benefits, not only medically but also economically, outweigh any risks. As far ask I know, no perfect medical procedures, devices or pharmaceuticals, none, that are perfectly safe or perfectly effective. Sometimes the ratio is small. For example, there are chemotherapy drugs that only add a few months to a patient’s life, usually with substantial side effects to the medication.
There are many food and nutritional fads floating around the internet that have limited scientific or medical evidence supporting their nutritional usefulness. One of them is the gluten-free diet that has become one of the most prevalent, and annoying, food crazes.
In Australia, there has been a 50% increase in hospital visits for anaphylaxis from 1998 to 2012, the most severe allergic reaction. Infants and toddlers accounted for much of this increase. Anaphylaxis is the most serious allergic reaction to anything including food.
What stumps a lot of researchers is why the increase? Has our food supply become more allergenic? Some blame the addition of GMOs to our food supply, but that’s nonsense. In fact, some very good research may point us toward new recommendations to prevent child food allergies.